Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The ‘Oxford-Kay Kendall Leukaemia Fund Graduate Scholarship’ based at the MRC WIMM, will commence in 2023.


A new DPhil scholarship has been endowed in the Division of Medical Sciences to be based at the MRC Weatherall Institute of Molecular Medicine within the Radcliffe Department of Medicine. Thanks to support from the Kay Kendall Leukaemia Fund (KKLF) and matched funding from the University of Oxford, the scholarship will support students to pursue research into leukaemia.

Available to applicants showing exceptional academic merit, the scholarship will cover course fees and a maintenance grant for the duration of the students’ study. The first Oxford-Kay Kendall Leukaemia Fund Graduate Scholar is expected to start in the academic year 2023-24.

Professor KJ Patel, Director of the MRC Weatherall Institute of Molecular Medicine, said: 'We are delighted to receive this generous support from the Kay Kendall Leukaemia Fund to endow a DPhil scholarship. KKLF’s commitment to advancing research into all areas of leukaemia will enable us to attract the very best scholars to Oxford.’